CD
DPLO

Christopher Davis’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Christopher Davis’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-481,187
Closed -$9.7M – 147
2018
Q1 		$9.7M Sell
481,187
-1,317,941
-73% -$30.7M 0.04% 107
2017
Q4 		$36.1M Buy
1,799,128
+93,894
+6% +$1.85M 0.15% 58
2017
Q3 		$35.3M Buy
1,705,234
+1,242
+0.1% +$21K 0.15% 64
2017
Q2 		$25.2M Buy
1,703,992
+71,846
+4% +$1.2M 0.11% 71
2017
Q1 		$26M Buy
+1,632,146
New +$23.5M 0.11% 66

Other funds holding DPLO

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Christopher Davis's DPLO Position: Q2 2018 in Review

Christopher Davis sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2018, closing a stake of 481,187 shares — an estimated $9.7M sold.

Christopher Davis first reported a position in DPLO in Q1 2017 and held it in 5 quarters. The position peaked at $36.1M in Q4 2017. 206 funds tracked by Wall St. Rank hold DPLO as of Q2 2018.

  • Christopher Davis reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2018 after selling out during the quarter.
  • Christopher Davis sold 481,187 DIPLOMAT PHARMACY, INC. shares in Q2 2018, an estimated $9.7M.
  • Christopher Davis first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2017 and held it in 5 quarters.
  • Christopher Davis's DIPLOMAT PHARMACY, INC. position peaked at $36.1M in Q4 2017.
  • 206 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2018.

Based on Davis Selected Advisers's 13F filing for Q2 2018, filed 13 Aug 2018.